Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Takes Up PhRMA Offer For Rx Discounts In Donut Hole, But Still Wants More Rebates

This article was originally published in The Pink Sheet Daily

Executive Summary

House health reform bill includes PhRMA's offer of 50 percent discounts on drugs for Medicare beneficiaries in the Part D donut hole, but also contains Medicaid-level rebates on drugs used by dual-eligibles.

You may also be interested in...



Feeling The August Reform Heat: PhRMA And Insurers Get Scorching Letters From Congress

Those involved in pushing comprehensive health care reform have taken a lot of heat this summer, and insurers and drug manufacturers are no exception

Feeling The August Reform Heat: PhRMA And Insurers Get Scorching Letters From Congress

Those involved in pushing comprehensive health care reform have taken a lot of heat this summer, and insurers and drug manufacturers are no exception

House Bill Would Expand Rx Market, But Negatives Draw PhRMA's Protest

The House health care reform bill contains a number of provisions that would greatly expand the market for pharmaceuticals, but the bill seeks a number of financial concessions from pharmaceutical manufacturers, prompting a statement of protest from the industry association

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS069693

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel